Literatur

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

In: Lancet 354, S. 635–639.

Weitere Veröffentlichungen:

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Weitere Informationen

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

Weitere Informationen

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

Weitere Informationen

Rembacken, B. J.; Snelling, A. M.; Hawkey, P. M.; Chalmers, D. M.; Axon, A. T. R. (1999): Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.